|
|
|
|
|
|
Madrigal Pharmaceuticals Inc (MDGL)
|
|
15.75 +0.13 (+0.83%)
|
8/18/2017 4:00pm
|
|
Open:
|
15.57
|
Pre. Close:
|
15.62
|
|
High:
|
15.87
|
Low:
|
15.57
|
|
Volume:
|
8,616
|
Market Cap:
|
196.80M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
16.05 - 16.44
|
16.44 - 16.83
|
|
Low:
|
15.05 - 15.23
|
15.23 - 15.41
|
|
Close:
|
15.41 - 15.89
|
15.89 - 16.38
|
|
|
|
|
|
|
Technical analysis (as of: 2017-08-18 4:43:40 PM)
|
|
Overall:
|
|
|
Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.
|
|
Target:
|
Six months: 18.92  One year: 22.10
|
|
Support:
|
Support1: 15.55 Support2: 15.15
|
|
Resistance:
|
Resistance1:
16.20 Resistance2: 18.92
|
|
Pivot:
|
15.77
|
|
Moving Averages:
|
MA(5): 15.80 MA(20): 15.73
MA(100): 15.65 MA(250): 15.24
|
|
MACD:
|
MACD(12,26):
0.05  Signal(12,26,9): 0.05
|
|
%K %D:
|
%K(14,3): 53.05 %D(3): 58.54
|
|
RSI:
|
RSI(14): 51.80
|
|
52-Week:
|
High: 18.24
Low: 8.74 Change(%): 69.0
|
|
Average Vol(K):
|
3-Month: 2262
10-Days 405
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.MDGL has closed above bottom band by 47.8%. Bollinger Bands are 57.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to MDGL's normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
Fri, 18 Aug 2017 19:52:30 GMT
Price Alert: Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) Stock Nears Resistance ...
Fri, 22 Jul 2016 15:22:30 GMT
Madrigal Pharmaceuticals Completes Merger with Synta to Create Leading ...
Mon, 25 Jul 2016 20:03:49 GMT
15.75
Mon, 19 Sep 2016 11:26:15 GMT
Madrigal Pharmaceuticals and Tarveda Therapeutics Announce Exclusive License ...
Thu, 11 May 2017 21:00:00 GMT
Madrigal Pharmaceuticals Reports 2017 First Quarter Financial Results
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
